Categories: News

Meiyume (Group) LTD Achieves EcoVadis Gold Rating for 2026, Reinforcing Commitment to Sustainable Beauty

HONG KONG, May 4, 2026 /PRNewswire/ — Meiyume (Group) LTD has achieved the EcoVadis Gold rating for 2026, with the company being in the 96th percentile globally and among the top-performing companies for sustainability.

- Advertisement -

EcoVadis evaluates companies across environment, labour and human rights, ethics, and sustainable procurement. The Gold rating reflects Meiyume’s strong performance and continued commitment to embedding sustainability across its supply chain.

- Advertisement -

A supplier’s commitment to sustainability is increasingly important to brands, as they work to meet rising regulatory requirements and evolving consumer expectations for transparency and responsible practices. In this landscape, choosing the right partners is essential. Partners like Meiyume play a key role in enabling more responsible, future-ready solutions while helping to strengthen sustainability standards across the supply chain.

- Advertisement -

A Holistic Sustainability Strategy: Meiyume’s 5Ps Framework

- Advertisement -

Meiyume’s sustainability approach is guided by its 5Ps framework: Product, Process, Places, People, and Principle, ensuring a comprehensive integration across the business:

- Advertisement -

Product – Advancing sustainable innovation in formulations and packaging

- Advertisement -

Process – Strengthening responsible sourcing and supply chain practices

- Advertisement -

Places – Enhancing operational efficiency and environmental performance

- Advertisement -

People – Fostering an inclusive and supportive workplace

- Advertisement -

Principle – Upholding strong governance and compliance standards

- Advertisement -

Sustainability as an Ongoing Journey

- Advertisement -

While the EcoVadis Gold rating marks an important milestone, Meiyume views sustainability as an ongoing journey. The company remains committed to strengthening its sustainability performance and supporting beauty and personal care brands in achieving their sustainability goals.

- Advertisement -

About Meiyume:

- Advertisement -

Formerly LF Beauty, Meiyume offers end-to-end beauty solutions—packaging, ODM, OEM —grounded in sustainability and insights. Powered by it’s Beauty Intelligence Platform and a global sourcing network, Meiyume brings visions to life with agility, intelligence, and responsibility.

- Advertisement -

https://meiyume.com/
2/F HK Spinners Industrial Building, Phases I & II, 800 Cheung Sha Wan Road, Kowloon, Hong Kong

- Advertisement -

Photo – https://mma.prnewswire.com/media/2968920/Meiyume_Ecovadis_Gold_2026.jpg
Logo – https://mma.prnewswire.com/media/2246462/5944472/without_tm_meiyume_logo_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/meiyume-group-ltd-achieves-ecovadis-gold-rating-for-2026-reinforcing-commitment-to-sustainable-beauty-302757059.html

- Advertisement -

Recent Posts

FemiCore (Official Website & Authenticity Notice 2026) Counterfeit Risks and What Consumers Should Know

New York City, NY, June 13, 2026 (GLOBE NEWSWIRE) -- The women's health supplement market…

7 hours ago

Hitch Open Ping-Pong Embodied (HOPE) AI Challenge Joins the 2026 World Humanoid Robot Games, Seeding Advanced Physical AI Against Human Performance

BEIJING, June 13, 2026 (GLOBE NEWSWIRE) -- The 2026 Hitch Open Ping-Pong Embodied AI Challenge…

7 hours ago

Crypto News Today: AlphaPepe Unveils AlphaSwap Early Access as Bitcoin Price Prediction Eyes $250,000

MONACO, June 12, 2026 (GLOBE NEWSWIRE) -- Crypto news today is turning toward AlphaPepe after…

7 hours ago

Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

MUMBAI, India, LONDON and ISELIN, N.J., June 13, 2026 /PRNewswire/ -- Hexaware Technologies [NSE: HEXT], a…

9 hours ago

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

 -- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI…

10 hours ago

Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

June 13, 2026 07:30 ET  | Source: Intellia Therapeutics, Inc. Data from HAELO Phase 3…

10 hours ago